S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack

WallachBeth Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WallachBeth Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WallachBeth Capital.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
uniQure stock logo
QURE
uniQure
$5.59
-2.8%
12/6/2016Target Lowered byWallachBeth Capital-Buy$27.00 -> $15.00N/AView details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/6/2016
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$9.07
-3.9%
9/27/2016Target Raised byWallachBeth Capital-Hold$15.00 -> $17.00N/AView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/27/2016
Vistagen Therapeutics, Inc. stock logo
VTGN
Vistagen Therapeutics
$5.07
-0.8%
7/7/2016Initiated byWallachBeth Capital-Buy$510.00N/AView details for WallachBeth Capital rating of Vistagen Therapeutics (NASDAQ:VTGN) on 7/7/2016
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
$2.55
+1.6%
7/5/2016Downgraded byWallachBeth Capital-Buy -> Hold$35.00N/AView details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 7/5/2016
uniQure stock logo
QURE
uniQure
$5.59
-2.8%
6/15/2016Target Lowered byWallachBeth Capital-Buy$60.00 -> $35.00N/AView details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 6/15/2016
Trevena, Inc. stock logo
TRVN
Trevena
$0.57
-1.7%
3/2/2016Initiated byWallachBeth Capital-Buy$450.00N/AView details for WallachBeth Capital rating of Trevena (NASDAQ:TRVN) on 3/2/2016
uniQure stock logo
QURE
uniQure
$5.59
-2.8%
12/1/2015Target Raised byWallachBeth Capital-Buy$33.00 -> $60.00N/AView details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/1/2015
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
$2.55
+1.6%
10/26/2015Initiated byWallachBeth Capital-Buy$34.00N/AView details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 10/26/2015
uniQure stock logo
QURE
uniQure
$5.59
-2.8%
8/28/2015Target Lowered byWallachBeth Capital-Buy$35.00 -> $33.00N/AView details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/28/2015
uniQure stock logo
QURE
uniQure
$5.59
-2.8%
8/7/2015Initiated byWallachBeth Capital-Buy$35.00N/AView details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/7/2015
Globus Medical, Inc. stock logo
GMED
Globus Medical
$54.45
+0.9%
3/2/2015Target Raised byWallachBeth Capital-Buy$26.00 -> $30.00N/AView details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 3/2/2015
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$9.07
-3.9%
2/13/2015Target Raised byWallachBeth Capital-Hold$15.00 -> $17.00N/AView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 2/13/2015
Akari Therapeutics, Plc stock logo
AKTX
Akari Therapeutics
$2.28
-3.0%
8/12/2014Initiated byWallachBeth Capital-Buy$340.00N/AView details for WallachBeth Capital rating of Akari Therapeutics (NASDAQ:AKTX) on 8/12/2014
Globus Medical, Inc. stock logo
GMED
Globus Medical
$54.45
+0.9%
8/6/2014Upgraded byWallachBeth Capital-Hold -> Buy$27.00 -> $24.00N/AView details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 8/6/2014
Ingredion Incorporated stock logo
INGR
Ingredion
$117.13
-0.4%
6/18/2014Initiated byWallachBeth Capital-Hold$16.00N/AView details for WallachBeth Capital rating of Ingredion (NYSE:INGR) on 6/18/2014
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$9.07
-3.9%
6/18/2014Initiated byWallachBeth Capital-Hold$16.00N/AView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 6/18/2014
Weibo Co. stock logo
WB
Weibo
$9.14
+0.2%
5/13/2014Downgraded byWallachBeth Capital-Buy -> Hold$4.00 -> $2.50N/AView details for WallachBeth Capital rating of Weibo (NASDAQ:WB) on 5/13/2014
Globus Medical, Inc. stock logo
GMED
Globus Medical
$54.45
+0.9%
2/27/2014Downgraded byWallachBeth Capital-Buy -> Hold$23.00 -> $27.00N/AView details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 2/27/2014
Globus Medical, Inc. stock logo
GMED
Globus Medical
$54.45
+0.9%
5/17/2013Initiated byWallachBeth Capital-Buy$19.00N/AView details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 5/17/2013
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$27.35
+1.0%
5/14/2013Downgraded byWallachBeth Capital-Buy -> Hold$40.00N/AView details for WallachBeth Capital rating of Patterson Companies (NASDAQ:PDCO) on 5/14/2013
aTyr Pharma, Inc. stock logo
LIFE
aTyr Pharma
$1.91
-0.5%
4/15/2013Downgraded byWallachBeth Capital-Buy -> Hold$1,036.00 -> $1,064.00N/AView details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 4/15/2013
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$218.00
+1.0%
4/12/2013Downgraded byWallachBeth Capital-Buy -> Hold$97.00N/AView details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 4/12/2013
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$576.33
+1.1%
4/4/2013Downgraded byWallachBeth Capital-Buy -> Hold$68.00 -> $76.00N/AView details for WallachBeth Capital rating of Thermo Fisher Scientific (NYSE:TMO) on 4/4/2013
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$50.89
+0.3%
3/25/2013Downgraded byWallachBeth Capital-Buy -> HoldN/AView details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 3/25/2013
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$171.12
+2.4%
3/4/2013Downgraded byWallachBeth Capital-Buy -> Hold$61.00N/AView details for WallachBeth Capital rating of Universal Health Services (NYSE:UHS) on 3/4/2013
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$118.85
0.0%
2/27/2013Target Raised byWallachBeth Capital-Buy$63.00 -> $70.00N/AView details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/27/2013
aTyr Pharma, Inc. stock logo
LIFE
aTyr Pharma
$1.91
-0.5%
2/6/2013Target Raised byWallachBeth Capital-Buy$1,036.00 -> $1,078.00N/AView details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 2/6/2013
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$311.98
+0.1%
2/6/2013Target Raised byWallachBeth Capital-Hold$31.00 -> $36.00N/AView details for WallachBeth Capital rating of HCA Healthcare (NYSE:HCA) on 2/6/2013
Waters Co. stock logo
WAT
Waters
$346.04
+2.6%
1/28/2013Upgraded byWallachBeth Capital-Hold -> Buy$87.00 -> $103.00N/AView details for WallachBeth Capital rating of Waters (NYSE:WAT) on 1/28/2013
aTyr Pharma, Inc. stock logo
LIFE
aTyr Pharma
$1.91
-0.5%
1/22/2013Target Raised byWallachBeth Capital-Buy$798.00 -> $1,078.00N/AView details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 1/22/2013
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$9.07
-3.9%
1/16/2013Target Raised byWallachBeth Capital-Hold$10.00 -> $13.00N/AView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 1/16/2013
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$50.89
+0.3%
1/8/2013Target Raised byWallachBeth Capital-Buy$44.50 -> $49.50N/AView details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 1/8/2013
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$9.07
-3.9%
12/18/2012Initiated byWallachBeth Capital-HoldN/AView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 12/18/2012
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$218.00
+1.0%
11/13/2012Upgraded byWallachBeth Capital-Hold -> Buy$91.00 -> $97.00N/AView details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 11/13/2012
Eversource Energy stock logo
ES
Eversource Energy
$58.41
-0.5%
11/13/2012Target Raised byWallachBeth Capital-Hold$3.50 -> $5.00N/AView details for WallachBeth Capital rating of Eversource Energy (NYSE:ES) on 11/13/2012
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
$22.18
+6.0%
10/1/2012Initiated byWallachBeth Capital-Buy$31.00N/AView details for WallachBeth Capital rating of Myriad Genetics (NASDAQ:MYGN) on 10/1/2012
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$27.35
+1.0%
9/19/2012Initiated byWallachBeth Capital-Buy$40.00N/AView details for WallachBeth Capital rating of Patterson Companies (NASDAQ:PDCO) on 9/19/2012
aTyr Pharma, Inc. stock logo
LIFE
aTyr Pharma
$1.91
-0.5%
9/10/2012Initiated byWallachBeth Capital-BuyN/AView details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 9/10/2012
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$76.88
+0.5%
9/6/2012Initiated byWallachBeth Capital-HoldN/AView details for WallachBeth Capital rating of Henry Schein (NASDAQ:HSIC) on 9/6/2012
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$50.89
+0.3%
9/4/2012Initiated byWallachBeth Capital-Buy$41.00N/AView details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 9/4/2012
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$1,267.98
+1.7%
8/28/2012Initiated byWallachBeth Capital-Hold$173.00N/AView details for WallachBeth Capital rating of Mettler-Toledo International (NYSE:MTD) on 8/28/2012
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$218.00
+1.0%
8/27/2012Initiated byWallachBeth Capital-Hold$91.00N/AView details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 8/27/2012
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$124.68
-0.2%
8/27/2012Initiated byWallachBeth Capital-HoldN/AView details for WallachBeth Capital rating of Quest Diagnostics (NYSE:DGX) on 8/27/2012
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$118.85
0.0%
8/27/2012Initiated byWallachBeth Capital-Buy$63.00N/AView details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 8/27/2012

MarketBeat Community Rating for WallachBeth Capital

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  23,161 (Vote Outperform)
Underperform Votes:  19,859 (Vote Underperform)
Total Votes:  43,020
MarketBeat's community ratings are surveys of what our community members think about WallachBeth Capital and other research firms. Vote "Outperform" if you believe WallachBeth Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WallachBeth Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools